Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction

Circ Heart Fail. 2021 Apr;14(4):e007840. doi: 10.1161/CIRCHEARTFAILURE.120.007840. Epub 2021 Apr 19.

Abstract

The health burden of heart failure with preserved ejection fraction is increasingly recognized. Despite improvements in diagnostic algorithms and established knowledge on the clinical trajectory, effective treatment options for heart failure with preserved ejection fraction remain limited, mainly because of the high mechanistic heterogeneity. Diagnostic scores, big data, and phenomapping categorization are proposed as key steps needed for progress. In the meantime, advancements in imaging techniques combined to high-fidelity pressure signaling analysis have uncovered right ventricular dysfunction as a mediator of heart failure with preserved ejection fraction progression and as major independent determinant of poor outcome. This review summarizes the current understanding of the pathophysiology of right ventricular dysfunction in heart failure with preserved ejection fraction covering the different right heart phenotypes and offering perspectives on new treatments targeting the right ventricle in its function and geometry.

Keywords: heart failure with preserved ejection fraction; phenotype; pulmonary hypertension; right heart.